icon-    folder.gif   Conference Reports for NATAP  
 
  11th IAS Conference on HIV Science 18-21 July 2021
Back grey_arrow_rt.gif
 
 
 
LONG-TERM (96-WEEK) SAFETY OF FOSTEMSAVIR (FTR) IN HEAVILY TREATMENT-EXPERIENCED (HTE) ADULTS INFECTED WITH MULTIDRUG-RESISTANT (MDR) HIV-1 (BRIGHTE PHASE 3 STUDY)
 
 
  IAS 2021 July 18-22
 
Bronagh Shepherd,1 Moti Ramgopal,2 Peter Ackerman,3 Shiven Chabria,3 Fangfang Du,4 Marcia Wang,4 Amy Pierce,5 Andrew Clark6
1GlaxoSmithKline, Uxbridge, UK; 2Midway Specialty Care Center, Fort Pierce, FL, USA; 3ViiV Healthcare, Branford, CT, USA; 4GlaxoSmithKline, Collegeville, PA, USA; 5ViiV Healthcare, Research Triangle Park, NC, USA; 6ViiV Healthcare, Brentford, UK

0722211

0722212

0722213

0722214

0722215